Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Comparative Aspects of the Hemipenial Architecture of the Arabian Horned Viper Cerastes gasperettii: Macroscopic and Microscopic Analysis With Evolutionary Perspectives.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2026
Same author

CD38-driven NAD⁺ depletion governs crypt structure and barrier dysfunction in fluorouracil-induced colonic mucositis: From metabolic collapse to architectural remodeling.

Tissue & cell·2026
Same author

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents.

International journal of molecular sciences·2026
Same author

Engineering Selenium-Chitosan Nanoparticles for Enhanced Hepatic Delivery of Sunitinib and Improved In Vitro Anticancer Activity in Hepatocellular Carcinoma Models.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Interrupting a mitochondrial DNA-driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis.

Tissue & cell·2026

Related Experiment Video

Updated: Apr 2, 2026

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

8.1K

A Spatial-Mechanistic Design Map for Microenvironment-Responsive Nanomaterials in Solid Tumors.

Rabab S Hamad1, Sameh Saber2, Ahmed Sameh3

  • 1Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 1, 2026
PubMed
Summary

Tumor microenvironment heterogeneity dictates nanomaterial delivery and function. Understanding these complex microdomains is crucial for improving drug targeting and therapeutic outcomes in solid tumors.

Keywords:
drug deliverystromal remodelingtranslational nanomedicinetumor microenvironmenttumor pathophysiologyvascular dysfunction

More Related Videos

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.8K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

846

Related Experiment Videos

Last Updated: Apr 2, 2026

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

8.1K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.8K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

846

Area of Science:

  • Nanomedicine and Tumor Biology
  • Biomaterials Science
  • Cancer Research

Background:

  • Solid tumors exhibit complex microenvironmental heterogeneity, partitioning into distinct microdomains.
  • Tumor microdomains critically regulate the entry, localization, and function of therapeutic agents.
  • Existing research often overlooks microenvironmental influences on nanomaterial behavior.

Purpose of the Study:

  • To present a microdomain-centered framework linking tumor biology and heterogeneity to nanomaterial behavior.
  • To emphasize clinically relevant tissue exposure over therapeutic outcomes for nanomaterial evaluation.
  • To propose standards for improved reproducibility and translation of nanomaterial research.

Main Methods:

  • Distinguished trans-vascular entry from intratumoral transport mechanisms.
  • Analyzed vascular, stromal, and interstitial factors influencing nanomaterial distribution.
  • Interpreted metabolic and signaling niches (hypoxic, acidic, protease-active) within the tumor microenvironment.

Main Results:

  • Tumor-level accumulation does not guarantee uniform cellular exposure due to transport barriers.
  • Vascular heterogeneity and stromal constraints significantly bias nanomaterial localization, often to perivascular regions.
  • Recurring mismatches exist between tumor architecture and nanomaterial design, leading to heterogeneous distribution and variable responses.

Conclusions:

  • A microdomain-centered approach is essential for understanding nanomaterial behavior in solid tumors.
  • Standardized spatial metrics and reporting practices are needed to improve cross-study translation.
  • Future research must integrate microenvironmental heterogeneity as a measurable variable for clinical translation.